12.09.2013 • Newsgreen energySolar Energyphotovoltaic

U.S. Solar Panel Installations Up 15% in Q2

The United States installed 832 megawatts of photovoltaic solar panels in the second quarter, a 15% increase from the prior period as booming business for utility-scale systems helped offset weaker demand for residential and commercial projects, according to an industry report.

Compared with the same period a year ago, the market grew a modest 1.5%.

According to a report released Thursday by research firm GTM Research and the Solar Energy Industries Association trade group, the U.S. residential solar market was flat from the prior quarter as installations fell 8% and 18%, respectively, in key solar markets Arizona and Hawaii.

Solar developers in Hawaii reported that changes in building permit fees and the state solar tax credit have made that market more difficult this year. In California, residential systems grew 4% from the first quarter.

Commercial installations fell 11% due to regulatory uncertainty and to reductions in incentives in markets like Massachusetts and Arizona.

The utility-scale solar market soared 42%, but the report noted that utilities in California and other key states have slowed down their procurement of power from new solar projects.

The average installed price of solar systems fell 9.3% to $3.05 per watt from $3.36 per watt in the first quarter. A year earlier, the average price was $3.43 a watt. Prices vary greatly state to state and project to project, however, GTM said. Residential system prices, for instance, ranged from $3 to $8 a watt. 

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.